glp 1 post bariatric surgery hypoglycemia Post-Bariatric glp 1 post bariatric surgery
Description
In an age where wellness discussions seem perpetual, Oprah Winfrey's revelation about GLP-1 medication not only highlights the drug's potential beyond weight loss, but also challenges conventional beliefs about addiction and emotional health, emphasising that understanding and biology are key in healing and transformation.
The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.
Novo Nordisk and Hims had clashed on and off for months as the telehealth firm marketed compounded versions of Novo's blockbuster GLP-1 drug Wegovy
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
Our findings provide valuable insights into the structural basis of functional versatility and therapeutic supremacy of tirzepatide and peptide 20
